Continuing declines in HIV diagnoses thanks to successful PrEP rollout in NSW


 Kirby Institute at UNSW, Friday July 2nd, 2021

New research from the Kirby Institute at UNSW Sydney shows that HIV transmissions are at historically low rates among almost 10,000 high-risk gay and bisexual men on pre-exposure prophylaxis (PrEP), the HIV prevention medication.

Low HIV rates persisted after PrEP moved from being available cost-free as part of a NSW clinical trial, to being available at a subsidised cost through the Australian Pharmaceutical Benefits Scheme (PBS) in 2018.

The research, funded by NSW Health and published today in The Lancet HIV, is the culmination of a three-year study called EPIC-NSW, which was the first study globally to measure the impact of PrEP on reducing HIV in a large population.


By J Pope

Your sidebar area is currently empty. Hurry up and add some widgets.